BMS-2

• CAT Number: I023514
• CAS Number: 888719-03-7
• Molecular Formula: C25H16F2N4O3
• Molecular Weight: 458.42
• Purity: 98%
• Synonyms: BMS2; BMS-2; BMS 2
• Target: c-Met/HGFR
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 1-(4-Fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxopyridine-3-carboxamide
• InChI: InChI=1S/C25H16F2N4O3/c26-15-3-6-17(7-4-15)31-13-1-2-19(25(31)33)24(32)30-16-5-8-22(20(27)14-16)34-21-10-12-29-23-18(21)9-11-28-23/h1-14H,(H,28,29)(H,30,32)
• InChIKey: OBSFXHDOLBYWRJ-UHFFFAOYSA-N
• SMILES: O=C(C1=CC=CN(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C5C(NC=C5)=NC=C4)C(F)=C3

BMS-2（Cat No.:I023514） is a tyrosine kinase inhibitor that targets multiple receptors including Met, Flt-3, and VEGFR2. It inhibits the kinase activity of these receptors, thereby interfering with their downstream signaling pathways involved in cell growth, survival, and angiogenesis. By blocking these receptors, BMS-2 may have potential therapeutic applications in conditions where aberrant signaling through these receptors contributes to disease progression.